UBS maintains a 'Neutral' rating on SXC Health Solutions (Nasdaq: SXCI), raises price target from $59 to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE